Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double Blind, Multiple Dose, Pharmacokinetic and Safety Study of SENS 401 in Healthy Subjects

NCT03071003 is registered in ClinicalTrials.gov with Simbec Research as lead sponsor.

NCT NCT03071003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03071003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double Blind, Multiple Dose, Pharmacokinetic and Safety Study of SENS 401 in Healthy Subjects
Lead sponsor
Simbec Research
Phase
Phase 1
Overall status
Completed
Start date
October 21, 2016
Completion date
October 16, 2017
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inner ear disease